Indore: A groundbreaking medical development befell at MGM Medical College‘s Maharaja Yashwantrao Hospital (MYH) with the introduction of CAR T-cell therapy, a state-of-the-art remedy for blood cancer.
“This cutting-edge remedy, beforehand accessible solely in a number of superior medical centres worldwide, is now accessible to sufferers in Central India,” mentioned MYH Superintendent Dr Ashok Yadav. He added that CAR T-cell remedy is a type of immunotherapy that includes genetically engineering a affected person’s T-cells to focus on and destroy most cancers cells.
“T-cells, a sort of white blood cell, are extracted from the affected person’s blood, modified in a laboratory to precise a selected antigen receptor, after which infused again into the affected person. These modified T-cells, generally known as CAR T-cells, are designed to recognise and assault most cancers cells, significantly these related to leukaemia and lymphoma,” he defined.
Dr Yadav mentioned that the Transfusion Medication Division and Bone Marrow Transplant Unit at MGM Medical School efficiently initiated CAR T-cell remedy for a affected person affected by B-cell acute lymphoblastic leukaemia (ALL). This marks a big milestone within the discipline of most cancers remedy in India.
“The process includes accumulating the affected person’s white blood cells, genetically modifying them, after which reinfusing them into the affected person,” he mentioned.
He claimed that the institute is the primary state govt-run medical school to have this facility. “Whereas the price of this remedy will be exorbitant in different nations (as excessive as Rs 4 crore in USA), the establishment is providing it at a fraction of the value (by round Rs 20-30 lakh), making it accessible to a bigger variety of sufferers,” he mentioned.
